{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:14:30Z","timestamp":1769602470618,"version":"3.49.0"},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/s0090-8258(21)00657-0","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T21:16:52Z","timestamp":1629235012000},"page":"S4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"S1","title":["A multicenter, open-label, randomized, phase III study to compare the efficacy and safety of lenvatinib in combination with pembrolizumab versus treatment of physician's choice in patients with advanced endometrial cancer"],"prefix":"10.1016","volume":"162","author":[{"given":"Vicky","family":"Makker","sequence":"first","affiliation":[]},{"given":"Nicoletta","family":"Colombo","sequence":"additional","affiliation":[]},{"given":"Antonio Casado","family":"Herr\u00e1ez","sequence":"additional","affiliation":[]},{"given":"Alessandro","family":"Santin","sequence":"additional","affiliation":[]},{"given":"Emeline","family":"Colomba","sequence":"additional","affiliation":[]},{"given":"David","family":"Miller","sequence":"additional","affiliation":[]},{"given":"Keiichi","family":"Fujiwara","sequence":"additional","affiliation":[]},{"given":"Sandro","family":"Pignata","sequence":"additional","affiliation":[]},{"given":"Sally","family":"Baron-Hay","sequence":"additional","affiliation":[]},{"given":"Isabelle","family":"Ray-Coquard","sequence":"additional","affiliation":[]},{"given":"Ronnie","family":"Shapira-Frommer","sequence":"additional","affiliation":[]},{"given":"Kimio","family":"Ushijima","sequence":"additional","affiliation":[]},{"given":"Jun","family":"Sakata","sequence":"additional","affiliation":[]},{"given":"Kan","family":"Yonemori","sequence":"additional","affiliation":[]},{"given":"Yong Man","family":"Kim","sequence":"additional","affiliation":[]},{"given":"Eva","family":"Guerra","sequence":"additional","affiliation":[]},{"given":"Ulus","family":"Sanli","sequence":"additional","affiliation":[]},{"given":"Mary","family":"McCormack","sequence":"additional","affiliation":[]},{"given":"Jie","family":"Huang","sequence":"additional","affiliation":[]},{"given":"Alan","family":"Smith","sequence":"additional","affiliation":[]},{"given":"Stephen","family":"Keefe","sequence":"additional","affiliation":[]},{"given":"Lea","family":"Dutta","sequence":"additional","affiliation":[]},{"given":"Robert","family":"Orlowski","sequence":"additional","affiliation":[]},{"given":"Domenica","family":"Lorusso","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821006570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825821006570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:54:56Z","timestamp":1758772496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825821006570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":0,"alternative-id":["S0090825821006570"],"URL":"https:\/\/doi.org\/10.1016\/s0090-8258(21)00657-0","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A multicenter, open-label, randomized, phase III study to compare the efficacy and safety of lenvatinib in combination with pembrolizumab versus treatment of physician's choice in patients with advanced endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0090-8258(21)00657-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}